An expert attendee draws from a wide range of study presentations to glean a few key conclusions for the daily practice of stroke neurologists.
Aiming for a systolic blood pressure below 140 mm Hg following intracerebral hemorrhage can amount to too much of a good thing, a new study finds. Here’s what the findings may mean for practice.
Mobile stroke units are gaining significant traction in the U.S. and around the world. A new paper looks back on the units’ time-to-treatment effects — and ahead to outcome and cost impacts.
The answer is yes, according to a new national database analysis, but the differences are limited and fairly focused on promptness of reperfusion therapy.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
The newly published DEFUSE 3 trial joins the DAWN trial in support of extending the time window for endovascular thrombectomy in selected patients with acute ischemic stroke.
Something’s going right in acute stroke therapy: Medicare data show that one-year mortality fell 18 percent from 2009 to 2013 in tandem with a 60 percent rise in IV tPA use.
A new study shows that when telemedicine is used to connect a hospital-based stroke neurologist with a mobile stroke treatment unit, intervention times are trimmed and technical failures can be kept rare.
A comprehensive review by Cleveland Clinic researchers finds that legislation promoting primary stroke centers is a significant differentiator between states with the most and the least such centers.